ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023
Year: 2023
Type: article
Abstract: In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of patients with cervical cancer. Given the large body of new evidence addressing the management of cervical cancer, the three sister societies jointly decided to update these evidence-based guidelines. The update includes new topics to provide comprehensive guidelines on all relevant issues of diagnosis and treatment in cervical cancer. To serve on the expert panel (27 experts across Europe) ESGO/ESTRO/ESP nominated practicing clinicians who are involved in managing patients with cervical cancer and have demonstrated leadership through their expertise in clinical care and research, national and international engagement, profile, and dedication to the topics addressed. To ensure the statements were evidence based, new data identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the international development group. Before publication, the guidelines were reviewed by 155 independent international practitioners in cancer care delivery and patient representatives. These updated guidelines are comprehensive and cover staging, management, follow-up, long-term survivorship, quality of life and palliative care. Management includes fertility sparing treatment, early and locally advanced cervical cancer, invasive cervical cancer diagnosed on a simple hysterectomy specimen, cervical cancer in pregnancy, rare tumors, recurrent and metastatic diseases. The management algorithms and the principles of radiotherapy and pathological evaluation are also defined.
Source: Radiotherapy and Oncology
Authors: David Cibula, Maria Rosaria Raspollini, François Planchamp, Carlos Centeno, Cyrus Chargari, Ana Felix, Daniela Fischerová, Daniela Jahnn-Kuch, Florence Joly, Christhardt Kohler, Sigurd Lax, Domenica Lorusso, Umesh Mahantshetty, Patrice Mathevet, Mr Raj Naik, Remi A Nout, Ana Oaknin, Fedro Peccatori, Jan Persson, Denis Querleu, Sandra Rubio Bernabé, Maximilian P. Schmid, Artem Stepanyan, Valentyn Svintsitskyi, Karl Tamussino, Ignacio Zapardiel, Jacob Christian Lindegaard
Institutions: Charles University, General University Hospital in Prague, Azienda Ospedaliero-Universitaria Careggi, Institut Bergonié, Universidad de Navarra, Pitié-Salpêtrière Hospital, Instituto Português de Oncologia Francisco Gentil, Universidade Nova de Lisboa, Medical University of Graz, Centre François Baclesse, Asklepios Klinik Altona, Asklepios, Asklepios Kliniken Hamburg, Johannes Kepler University of Linz, Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Centre Hospitalier Universitaire Vaudois, Hôpital Orthopédique de la Suisse Romande, Gateshead Health NHS Foundation Trust, Erasmus MC, Erasmus MC Cancer Institute, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, European Institute of Oncology, Lund University, Skåne University Hospital, Hôpitaux Universitaires de Strasbourg, Istituti di Ricovero e Cura a Carattere Scientifico, Clinica Universidad de Navarra, Medical University of Vienna, National Cancer Institute, Hospital Universitario La Paz, Aarhus University Hospital
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,210
OpenAlex ID: W4367602153